The Role of Baseline 18F-FDG PET/CT for Survival Prognosis in NSCLC Patients Undergoing Immunotherapy: A Systematic Review and Meta-Analysis

By
Jamie Kang
-
0
218
Researchers investigated the prognostic ability of baseline 18F-FDG PET/CT in patients with non-small-cell lung cancer (NSCLC) receiving immunotherapy.
[Therapeutic Advances In Medical Oncology]
Full Article